Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Arcila
    Arcila
  3. Sofocleous
    Sofocleous
  4. Carlsson
    Carlsson
  5. Cornelis
    Cornelis
  6. Abida
    Abida
  7. Erinjeri
    Erinjeri
  8. Solomon
    Solomon
  9. Coleman
    Coleman
  10. Morris
    Morris

Groups

  1. Department of Medicine (75)
  2. Solid Tumor Oncology Division (54)
  3. Surgery (54)
  4. Radiology, Department of (45)
  5. Population Sciences Research Program (43)
  6. Sloan Kettering Institute Postdocs (42)
  7. Department of Pathology and Laboratory Medicine (40)
  8. Epidemiology and Biostatistics (32)
  9. Center for Pancreatic Cancer Research (29)
  10. Survivorship Research (29)
Search Within
  1. "2023"
Formats
  1. Journal Article (83)
  2. Meeting Abstract (69)
  3. Editorial (21)
  4. Review (21)
  5. Correspondence (17)
  6. Guidelines (16)
  7. Research Letter (5)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (75)
  2. Solid Tumor Oncology Division (54)
  3. Surgery (54)
  4. Radiology, Department of (45)
  5. Population Sciences Research Program (43)
  6. Sloan Kettering Institute Postdocs (42)

More Groups

People
  1. Andrew Vickers (12)
  2. Constantinos Sofocleous (10)
  3. Maria Arcila (10)
  4. Francois Cornelis (9)
  5. Sigrid Carlsson (9)
  6. Vlasios Sotirchos (9)

More People

Years
  1. 2023 (234)
Publications
  1. Journal of Vascular and Interventional Radiology (33)
  2. European Urology (32)
  3. Journal of Molecular Diagnostics (23)
  4. Journal of Urology (21)
  5. Lancet Oncology (15)
  6. Lancet (14)

More Publications

Results (234)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The large hidden prevalence rate of cancer using backward induction method reveals screening opportunity in earlier stages
    Meeting Abstract

    ElHabr, A. K.; Tyson, C.; Cao, X.; Merdan, S.; Raoof, S.; Ozbay, A. B.; Limburg, P.; Beer, T. M.; Deshmukh, A. A.; Chhatwal, J.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Real-world treatment patterns, healthcare resource utilization (HRU) and costs for relapsed/refractory (R/R) large B-cell lymphoma (LBCL): Chimeric antigen receptor T-cell (CAR T) and monoclonal antibodies (MAB) therapies
    Meeting Abstract

    Feng, C.; Murphy, L.; Engel-Nitz, N.; Nguyen, A.; Patel, A.; DuCharme, M.; Fu, C.; Shah, G.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Patient characteristics, treatment patterns, and factors of biomarker testing among patients with advanced non-small cell lung cancer (ANSCLC) in the US, 2012-2020
    Meeting Abstract

    Yang, M.; MacEwan, J. P.; Honnold, R.; McClain, M. R.; O'Hara, R.; Liu, F.; Paik, P.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Guidelines for reporting observational research in urology: The importance of clear reference to causality
    Editorial

    Vickers, A. J.; Assel, M.; Dunn, R. L.; Zabor, E. C.; Kattan, M. W.; van Smeden, M.; Dahly, D.
    Urology (2023)

    Fulltext@MSK | Save
  • 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A systematic review
    Review

    Bergengren, O.; Pekala, K. R.; Matsoukas, K.; Fainberg, J.; Mungovan, S. F.; Bratt, O.; Bray, F.; Brawley, O.; Luckenbaugh, A. N.; Mucci, L.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Health utility analysis of tepotinib in patients with non-small cell lung cancer harboring MET exon 14 skipping
    Journal Article

    Yang, M.; Vioix, H.; Hook, E. S.; Hatswell, A. J.; Batteson, R. L.; Gaumond, B. R.; O'Brate, A.; Popat, S.; Paik, P. K.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Re: Banks et al.: Ophthalmologic involvement in adults with histiocytic disorders: Clinical presentation and treatment outcomes (Ophthalmology. 2023;130:77-86)
    Correspondence

    Francis, J. H.; Abramson, D. H.; Diamond, E. L.
    Ophthalmology (2023)

    Fulltext@MSK | Save
  • Re: A comprehensive 6-mo prostate cancer patient empowerment program decreases psychological distress among men undergoing curative prostate cancer treatment: A randomized clinical trial
    Editorial

    Majumdar, J. R.; Carlsson, S. V.
    European Urology (2023)

    Fulltext@MSK | Save
  • Rucaparib for the treatment of metastatic castration-resistant prostate cancer associated with a DNA damage repair gene alteration: Final results from the phase 2 TRITON2 study
    Journal Article

    Abida, W.; Campbell, D.; Patnaik, A.; Bryce, A. H.; Shapiro, J.; Bambury, R. M.; Zhang, J.; Burke, J. M.; Castellano, D.; Font, A.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • PARP inhibitors for prostate cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) blues
    Editorial

    Beije, N.; Abida, W.; Antonarakis, E. S.; Castro, E.; de Wit, R.; Fizazi, K.; Gillessen, S.; Hussain, M.; Mateo, J.; Morris, M. J.; more...
    European Urology (2023)

    Fulltext@MSK | Save